Backed by strong numbers, Gilead takes to social media to market one-of-a-kind drug to prevent HIV

The success of the only FDA-approved drug to prevent infection of the AIDS virus — and the potential of reaching more people at risk of contracting HIV — is prompting Gilead Sciences Inc. to boost its direct-to-consumer marketing on Snapchat, Tumblr and other social media and dating sites. It is a somewhat controversial shift in Foster City-based Gilead's strategy around th e marketing of the drug, called Truvada, for what is known as pre-exposure prophylaxis, or PrEP. Before PrEP won Food and…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news